ArticleProceedings of the National Academy of Sciences of the United States of America2022

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer.

Daniel R Principe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.